KRAS Mutations, Potential Biomarkers for the Identification of Non-small-Cell Lung Cancer Patients That May Benefit From Immunotherapy-Based Treatments - L. Robado De Lope; R. Serna-Blasco; P. Mediavilla; V. Calvo; A. Collazo-Lorduy; S. Peña Cabia; P. Diz Tain; V. González-Rumayor; A. Romero; M. Provencio (The Journal of Liquid Biopsy)